Systematic review of 21 studies: CRE infection was associated with higher hospital costs, longer stay (mean difference 14.16 days) and higher mortality (OR 1.96) vs carbapenem-susceptible Enterobacterales infection; costs were narratively synthesised.
Meta-analysisn = 21 studies
Shen et al. A systematic review and meta-analysis of the economic burden of carbapenem-resistant Enterobacterales (CRE) infection